Package 81749-004-01

Brand: tarpeyo

Generic: budesonide
NDC Package

Package Facts

Identity

Package NDC 81749-004-01
Digits Only 8174900401
Product NDC 81749-004
Description

120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01)

Marketing

Marketing Status
Marketed Since 2021-12-15
Brand tarpeyo
Generic budesonide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48e9b876-94c8-7c9f-e063-6294a90adcef", "openfda": {"nui": ["N0000175576", "N0000175450"], "unii": ["Q3OKS62Q6X"], "rxcui": ["2587883", "2587889"], "spl_set_id": ["938cada4-d6bf-4252-836f-dd40f9eadb4d"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Calliditas Therapeutics AB"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01)", "package_ndc": "81749-004-01", "marketing_start_date": "20211215"}], "brand_name": "Tarpeyo", "product_id": "81749-004_48e9b876-94c8-7c9f-e063-6294a90adcef", "dosage_form": "CAPSULE, DELAYED RELEASE", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "81749-004", "generic_name": "budesonide", "labeler_name": "Calliditas Therapeutics AB", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tarpeyo", "active_ingredients": [{"name": "BUDESONIDE", "strength": "4 mg/1"}], "application_number": "NDA215935", "marketing_category": "NDA", "marketing_start_date": "20211215", "listing_expiration_date": "20271231"}